Aflac, the number one provider of supplemental insurance in the United States, and recognized six times by Ethisphere as one of the World’s Most Ethical Companies, is once again teaming with Macy’s to produce and sell the 2012 Aflac Holiday duck . This is the twelfth year that Aflac and Macy’s are selling the annual plush duck, with all net proceeds going to support research and treatment for childhood cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58454-aflac-macys-annual-holiday-duck-design-pediatric-cancer-patient-atlanta
This Sunday, October 10, NASCAR driver Carl Edwards and his crew will unveil a special new Aflac Duck Wingman Bead of Courage to show kids with serious illnesses like cancer that they are not alone in their fight against the disease. The new bead is part of the Aflac Duck’s 10th birthday celebration, as the Aflac Duck shares his birthday wish for people across the nation to help give kids facing cancer renewed strength and a reason to smile.
To view Multimedia News Release, go to http://www.multivu.com/players/English/45857-Aflac-Bead-of-Courage/
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
Clayton, one of the largest home builders in America, helped fulfill the dreams of an East Tennessee Children’s Hospital cancer patient by giving him the opportunity to design a Clayton home using CAD software commonly used at home building facilities.
Jake Clark, 16, became an honorary member of the Clayton team on Nov. 22 during a special ‘Team Jake’ celebration event at a home building facility in Bean Station, Tenn. His interests in construction projects with his dad, a home contractor, and his talents in drawing and 3D design made Jake the perfect fit to visit Clayton. While visiting the home building facility, the cancer survivor sat with a home designer and created a home model floor plan of his own, which was named “The Jake” in his honor.
To view the multimedia release go to:
https://www.multivu.com/players/English/80116510-clayton-honors-young-cancer-survivor/
With the introduction of Abbott's iDesign Dx system, U.S. ophthalmologists now have a diagnostic tool that can capture five optical measurements in one three-second scan to determine the patient's visual abnormalities. This highly advanced diagnostic tool measures the internal optics and surface of the eye more precisely than conventional methods, allowing doctors to fully evaluate imperfections that result in poor vision. Obtaining these measurements in one three-second scan enables ophthalmologists to screen patients more efficiently to determine if they are eligible for LASIK or other refractive surgery and to assist in diagnosis of other conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64467-abbott-idesign-dx-system-available-for-opthalmologists-and-patients
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
